CEA (CEA, Carcinoembryonic Antigen, CEA (Carcino Embryonic Antigen))

SRL
Carcinoembryonic Antigen (CEA)
CARCINOEMBRYONIC ANTIGEN (CEA)
Days : Daily, Cut Off : 11AM
Report : Same Day
Quest
Carcinoembryonic Antigen (CEA)
Carcinoembryonic Antigen (CEA)
Days : Daily, Cut Off : 11AM
Report : Same Day 7:30 PM
Metropolis
CEA Carcino Embryonic Antigen Body Fluid
CEA
Days : Daily, Cut Off : 11AM
Report : After 6 hrs
Thyrocare
CARCINO EMBRYONIC ANTIGEN (CEA)
CARCINO EMBRYONIC ANTIGEN (CEA)
Days : Daily, Cut Off : 11AM
Report : Next Day
Oncquest
CEA (Carcino Embryonic Antigen)
Components not available!
Days : Every day if received before 1:00 p.m.
Report : Same Day by 7:00 p.m.
City X-Ray -old
CEA
Components not available!
Days :
Report : 6 hour(s)
City X-Ray -old
CEA
Components not available!
Days :
Report : 6 hour(s)
Origin
CEA -Carcino Embryonic Antigen - By Chemiluminiscence
Components not available!
Days :
Report :
Pathcare
Bilirubin (Total + Direct)
Components not available!
Days : Daily
Report : 11:00/19:00
Oncquest Medlife
CEA (Carcino Embryonic Antigen)
Components not available!
Days :
Report :
Oncquest Lifespan
CEA (Carcino Embryonic Antigen)
Components not available!
Days :
Report :
1mg_Pathcare
Bilirubin (Total, Direct and Indirect)
Components not available!
Days :
Report :

Basic Detail

Specimen
Test Method Daily: 8am to 3. 30pm
Report After 6 Hrs
Test method CMIA
temperature Room Temperature : 2D;;2 to 8 Degree C : NA;;-20 Degree C : NA

Associated Diseases

Colon Cancer Ovarian Cancer Breast Cancer Pancreas Cancer

Why Get Tested

Primarily to monitor cancer treatment, including response to therapy and recurrence; as an indicator of the amount of cancer or size of tumor present (tumor burden) and to assist in determining prognosis and cancer staging; to determine if cancer has spread (metastasis); occasionally as follow up to a positive screening test for cancer, to help determine whether cancer is present in the body, though it is not useful as a general population screening test

When Get Tested

When you have been diagnosed with colon, pancreas, breast, lung, ovarian, medullary thyroid or other cancer prior to starting cancer treatment and then, if elevated, at intervals during and after therapy; occasionally when cancer is suspected but not confirmed to aid in its detection

Specimen

Test Preparation

None